EdgarLookup

NOBILITY HOMES INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that NOBILITY HOMES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
16%
Profit Margin
Net income ÷ revenue
12.6%
Return on Assets
Net income ÷ assets
0.11x
Debt-to-Equity
Total liabilities ÷ equity
+1.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $52.67M Jan 30, 2026
FY2025 Nov 2, 2024 $51.93M Jan 30, 2026
FY2024 Nov 4, 2023 $63.32M Jan 30, 2025
FY2023 Nov 5, 2022 $51.52M May 20, 2024
FY2022 Nov 6, 2021 $45.06M Feb 1, 2023
FY2021 Oct 31, 2020 $41.61M Feb 4, 2022
FY2020 Nov 2, 2019 $46.35M Jan 29, 2021
FY2019 Nov 3, 2018 $41.88M Jan 31, 2020
FY2018 Nov 4, 2017 $37.54M Jan 31, 2019

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Nov 4, 2017 $37.54M Jan 26, 2018
FY2016 Nov 5, 2016 $34.05M Jan 27, 2017
FY2015 Oct 31, 2015 $27.84M Jan 28, 2016
FY2014 Nov 1, 2014 $21.15M Jan 28, 2015
FY2013 Nov 2, 2013 $18.53M Jan 28, 2014
FY2012 Nov 3, 2012 $15.83M Jul 8, 2013
FY2011 Nov 5, 2011 $13.43M Apr 2, 2013
FY2011 Nov 6, 2010 $14.86M Apr 2, 2013

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $16.79M Jan 30, 2026
FY2025 Nov 2, 2024 $17.42M Jan 30, 2026
FY2024 Nov 4, 2023 $21.49M Jan 30, 2025
FY2023 Nov 5, 2022 $14.90M May 20, 2024
FY2022 Nov 6, 2021 $11.43M Feb 1, 2023
FY2021 Oct 31, 2020 $12.13M Feb 4, 2022
FY2020 Nov 2, 2019 $13.65M Jan 29, 2021
FY2019 Nov 3, 2018 $10.68M Jan 31, 2020
FY2018 Nov 4, 2017 $8.66M Jan 31, 2019
FY2017 Nov 5, 2016 $7.94M Jan 26, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $8.45M Jan 30, 2026
FY2025 Nov 2, 2024 $8.61M Jan 30, 2026
FY2024 Nov 4, 2023 $10.90M Jan 30, 2025
FY2023 Nov 5, 2022 $7.23M May 20, 2024
FY2022 Nov 6, 2021 $5.40M Feb 1, 2023
FY2021 Oct 31, 2020 $5.98M Feb 4, 2022
FY2020 Nov 2, 2019 $8.81M Jan 29, 2021
FY2019 Nov 3, 2018 $4.96M Jan 31, 2020
FY2018 Nov 4, 2017 $3.31M Jan 31, 2019
FY2017 Nov 5, 2016 $5.97M Jan 26, 2018

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $10.04M Jan 30, 2026
FY2025 Nov 2, 2024 $9.58M Jan 30, 2026
FY2024 Nov 4, 2023 $13.40M Jan 30, 2025
FY2023 Nov 5, 2022 $8.43M May 20, 2024
FY2022 Nov 6, 2021 $6.15M Feb 1, 2023
FY2021 Oct 31, 2020 $7.15M Feb 4, 2022
FY2020 Nov 2, 2019 $8.30M Jan 29, 2021
FY2019 Nov 3, 2018 $5.72M Jan 31, 2020
FY2018 Nov 4, 2017 $4.36M Jan 31, 2019
FY2017 Nov 5, 2016 $4.15M Jan 26, 2018

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $6.75M Jan 30, 2026
FY2025 Nov 2, 2024 $7.84M Jan 30, 2026
FY2024 Nov 4, 2023 $8.09M Jan 30, 2025
FY2023 Nov 5, 2022 $6.48M May 20, 2024
FY2022 Nov 6, 2021 $5.29M Feb 1, 2023
FY2021 Oct 31, 2020 $4.98M Feb 4, 2022
FY2020 Nov 2, 2019 $5.35M Jan 29, 2021
FY2019 Nov 3, 2018 $4.96M Jan 31, 2020
FY2018 Nov 4, 2017 $4.31M Jan 31, 2019
FY2017 Nov 5, 2016 $3.78M Jan 26, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $4.16M Jan 30, 2026
FY2025 Nov 2, 2024 $7.05M Jan 30, 2026
FY2024 Nov 4, 2023 $10.12M Jan 30, 2025
FY2023 Nov 5, 2022 ($7.83M) May 20, 2024
FY2022 Nov 6, 2021 $13.35M Feb 1, 2023
FY2021 Oct 31, 2020 $6.91M Feb 4, 2022
FY2020 Nov 2, 2019 $4.66M Jan 29, 2021
FY2019 Nov 3, 2018 $8.29M Jan 31, 2020
FY2018 Nov 4, 2017 $3.77M Jan 31, 2019
FY2013 Nov 2, 2013 $3.30M Jan 28, 2014

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $179.8K Jan 30, 2026
FY2025 Nov 2, 2024 $182.1K Jan 30, 2026
FY2024 Nov 4, 2023 $506.8K Jan 30, 2025
FY2023 Nov 5, 2022 $1.25M May 20, 2024
FY2022 Nov 6, 2021 $1.89M Feb 1, 2023
FY2021 Oct 31, 2020 $318.2K Feb 4, 2022
FY2020 Nov 2, 2019 $447.4K Jan 29, 2021
FY2019 Nov 3, 2018 $607.0K Jan 31, 2020
FY2018 Nov 4, 2017 $364.7K Jan 31, 2019
FY2017 Nov 5, 2016 $829.0K Jan 26, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $67.15M Jan 30, 2026
FY2025 Nov 2, 2024 $66.60M Jan 30, 2026
FY2024 Nov 4, 2023 $65.70M Jan 30, 2025
FY2023 Nov 5, 2022 $62.36M May 20, 2024
FY2022 Nov 6, 2021 $66.18M Feb 1, 2023
FY2021 Oct 31, 2020 $59.83M Feb 4, 2022
FY2020 Nov 2, 2019 $58.42M Jan 29, 2021
FY2019 Nov 3, 2018 $57.01M Jan 31, 2020
FY2018 Nov 4, 2017 $54.15M Jan 31, 2019
FY2017 Nov 5, 2016 $50.91M Jan 26, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $6.43M Jan 30, 2026
FY2025 Nov 2, 2024 $10.00M Jan 30, 2026
FY2022 Nov 5, 2022 $14.44M Feb 1, 2023
FY2022 Nov 6, 2021 $16.87M Feb 1, 2023
FY2021 Oct 31, 2020 $8.88M Feb 4, 2022
FY2020 Nov 2, 2019 $8.95M Jan 29, 2021
FY2019 Nov 3, 2018 $7.95M Jan 31, 2020
FY2018 Nov 4, 2017 $6.73M Jan 31, 2019
FY2017 Nov 5, 2016 $6.25M Jan 26, 2018
FY2016 Oct 31, 2015 $3.35M Jan 27, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $60.71M Jan 30, 2026
FY2025 Nov 2, 2024 $56.60M Jan 30, 2026
FY2025 Nov 4, 2023 $52.72M Jan 30, 2026
FY2024 Nov 5, 2022 $47.92M Jan 30, 2025
FY2023 Nov 6, 2021 $49.31M May 20, 2024
FY2022 Oct 31, 2020 $50.94M Feb 1, 2023
FY2020 Nov 2, 2019 $49.47M Jan 29, 2021
FY2020 Nov 3, 2018 $49.07M Jan 29, 2021
FY2019 Nov 4, 2017 $47.41M Jan 31, 2020
FY2018 Nov 5, 2016 $44.67M Jan 31, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $79.04M Jan 30, 2026
FY2025 Nov 2, 2024 $74.68M Jan 30, 2026
FY2024 Nov 4, 2023 $70.97M Jan 30, 2025
FY2023 Nov 5, 2022 $63.44M May 20, 2024
FY2022 Nov 6, 2021 $59.74M Feb 1, 2023
FY2021 Oct 31, 2020 $57.98M Feb 4, 2022
FY2020 Nov 2, 2019 $55.30M Jan 29, 2021
FY2019 Nov 3, 2018 $50.35M Jan 31, 2020
FY2018 Nov 4, 2017 $46.17M Jan 31, 2019
FY2017 Nov 5, 2016 $43.46M Jan 26, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 $13.23M Jan 30, 2026
FY2025 Nov 2, 2024 $13.52M Jan 30, 2026
FY2024 Nov 4, 2023 $13.88M Jan 30, 2025
FY2023 Nov 5, 2022 $16.65M May 20, 2024
FY2022 Nov 6, 2021 $36.13M Feb 1, 2023
FY2021 Oct 31, 2020 $30.31M Feb 4, 2022
FY2021 Nov 2, 2019 $22.53M Feb 4, 2022
FY2020 Nov 3, 2018 $28.36M Jan 29, 2021
FY2019 Nov 4, 2017 $27.91M Jan 31, 2020
FY2018 Nov 5, 2016 $24.56M Jan 31, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 2 Jan 30, 2026
FY2025 Nov 2, 2024 2 Jan 30, 2026
FY2024 Nov 4, 2023 3 Jan 30, 2025
FY2023 Nov 5, 2022 2 May 20, 2024
FY2022 Nov 6, 2021 1 Feb 1, 2023
FY2021 Oct 31, 2020 1 Feb 4, 2022
FY2020 Nov 2, 2019 2 Jan 29, 2021
FY2019 Nov 3, 2018 1 Jan 31, 2020
FY2018 Nov 4, 2017 0 Jan 31, 2019
FY2017 Nov 5, 2016 1 Jan 26, 2018

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 2 Jan 30, 2026
FY2025 Nov 2, 2024 2 Jan 30, 2026
FY2024 Nov 4, 2023 3 Jan 30, 2025
FY2023 Nov 5, 2022 2 May 20, 2024
FY2022 Nov 6, 2021 1 Feb 1, 2023
FY2021 Oct 31, 2020 1 Feb 4, 2022
FY2020 Nov 2, 2019 2 Jan 29, 2021
FY2019 Nov 3, 2018 1 Jan 31, 2020
FY2018 Nov 4, 2017 0 Jan 31, 2019
FY2017 Nov 5, 2016 1 Jan 26, 2018

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Nov 1, 2025 3.25M Jan 30, 2026
FY2025 Nov 2, 2024 3.27M Jan 30, 2026
FY2024 Nov 4, 2023 3.27M Jan 30, 2025
FY2023 Nov 5, 2022 3.37M May 20, 2024
FY2022 Nov 6, 2021 3.53M Feb 1, 2023
FY2021 Oct 31, 2020 3.63M Feb 4, 2022
FY2020 Nov 2, 2019 3.66M Jan 29, 2021
FY2019 Nov 3, 2018 3.87M Jan 31, 2020
FY2018 Nov 4, 2017 4.00M Jan 31, 2019